Privia Health Group, Inc. to Post Q4 2022 Earnings of ($0.01) Per Share, SVB Leerink Forecasts (NASDAQ:PRVA)

Privia Health Group, Inc. (NASDAQ:PRVAGet Rating) – Equities researchers at SVB Leerink issued their Q4 2022 earnings per share estimates for Privia Health Group in a research report issued on Friday, November 11th. SVB Leerink analyst W. Mayo anticipates that the company will post earnings of ($0.01) per share for the quarter. SVB Leerink has a “Outperform” rating and a $39.00 price objective on the stock. The consensus estimate for Privia Health Group’s current full-year earnings is ($0.26) per share.

Other analysts also recently issued reports about the company. Truist Financial increased their price objective on Privia Health Group from $48.00 to $54.00 and gave the stock a “buy” rating in a research note on Wednesday, September 7th. Guggenheim lifted their price objective on shares of Privia Health Group from $36.00 to $51.00 and gave the stock a “buy” rating in a report on Friday, August 12th. Cowen upped their target price on shares of Privia Health Group from $35.00 to $44.00 and gave the stock an “outperform” rating in a research note on Friday, August 12th. Canaccord Genuity Group dropped their price target on shares of Privia Health Group from $50.00 to $43.00 in a research report on Friday. Finally, Credit Suisse Group upped their price objective on shares of Privia Health Group from $33.00 to $41.00 and gave the stock an “outperform” rating in a research report on Friday, August 12th. Eleven investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $42.18.

Privia Health Group Price Performance

PRVA opened at $26.84 on Monday. The firm has a market capitalization of $2.99 billion, a PE ratio of -74.55 and a beta of 0.99. Privia Health Group has a fifty-two week low of $17.99 and a fifty-two week high of $44.64. The company’s 50-day moving average is $34.70 and its 200 day moving average is $32.07.

Privia Health Group (NASDAQ:PRVAGet Rating) last issued its quarterly earnings data on Thursday, August 11th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.08). Privia Health Group had a negative net margin of 3.02% and a negative return on equity of 6.94%. The business had revenue of $335.54 million for the quarter, compared to analyst estimates of $312.04 million.

Insiders Place Their Bets

In other Privia Health Group news, EVP Thomas Bartrum sold 35,000 shares of the stock in a transaction dated Friday, November 4th. The shares were sold at an average price of $30.56, for a total transaction of $1,069,600.00. Following the completion of the transaction, the executive vice president now owns 91,355 shares in the company, valued at $2,791,808.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Thomas Bartrum sold 35,000 shares of the firm’s stock in a transaction that occurred on Friday, November 4th. The shares were sold at an average price of $30.56, for a total value of $1,069,600.00. Following the completion of the transaction, the executive vice president now directly owns 91,355 shares in the company, valued at $2,791,808.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Matthew Shawn Morris sold 15,625 shares of the stock in a transaction that occurred on Thursday, November 3rd. The stock was sold at an average price of $30.57, for a total transaction of $477,656.25. Following the completion of the sale, the chief executive officer now owns 121,739 shares in the company, valued at $3,721,561.23. The disclosure for this sale can be found here. Insiders sold 1,272,362 shares of company stock valued at $44,784,075 over the last ninety days. 57.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Privia Health Group

Several institutional investors have recently modified their holdings of PRVA. Assetmark Inc. grew its position in Privia Health Group by 119.4% during the 2nd quarter. Assetmark Inc. now owns 893 shares of the company’s stock worth $26,000 after acquiring an additional 486 shares during the last quarter. First Horizon Advisors Inc. grew its holdings in shares of Privia Health Group by 4,330.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,019 shares of the company’s stock worth $29,000 after acquiring an additional 996 shares during the period. Signaturefd LLC bought a new position in shares of Privia Health Group in the 3rd quarter worth approximately $32,000. Nisa Investment Advisors LLC purchased a new position in shares of Privia Health Group in the 2nd quarter valued at approximately $46,000. Finally, Point72 Hong Kong Ltd bought a new stake in shares of Privia Health Group during the first quarter valued at approximately $47,000. 62.81% of the stock is currently owned by institutional investors.

Privia Health Group Company Profile

(Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Further Reading

Earnings History and Estimates for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.